1,721,410 research outputs found
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Novel antibacterial strategies with emphasis on the characterization of β-Lactamases and β-Lactamase inhibitors
Full text linkThis Thesis records my involvement and contributions to the discovery, evaluation
and characterization of novel antibacterial strategies. My Ph.D. project focussed on
the characterization of a series of novel extended spectrum TEM/SHV
β-lactamases and plasmid mediated Class C enzymes. This, coupled with research
which I conducted in India on the prolific widespread carriage of resistant
organisms, provided me with an excellent insight into the need for novel
antibacterial agents to combat the rising tide of resistant organisms. Subsequently,
on joining SmithKline Beecham in 1990 I performed research that led to the
discovery and characterization of a variety of novel inhibitors of serine
(β-lactamases. I also led a research initiative which successfully characterized a
variety of new metallo-β-lactamases and identified novel inhibitors of this group
of β-lactamases. Furthermore, these compounds demonstrated some potential for
combating this emerging resistance mechanism. In 1995 my interests focussed on
the exploitation of bacterial genomics for the identification and characterization of
novel antibacterial targets. I initiated projects to evaluate fatty acid biosynthesis,
cell wall biosynthesis, aromatic amino acid biosynthesis, cell division and protein
secretion as antibacterial strategies. This work provided the first ever identification
and characterization of the Gram positive cocci homologs of FabI (enoyl ACP
reductase, fatty acid biosynthesis), MurA (UDP- N-acetylglucosamine enolpyruvyl
transferase, peptidoglycan biosynthesis), EPSP synthase (5-enolpyruvylshikimate-
3-phosphate synthase, aromatic amino acid biosynthesis), FtsA, FtsZ (cell division)
and SRP (signal recognition particle, protein secretion). It is my hope that this
work will either directly or indirectly facilitate the discovery of pioneer antibacterial
agents urgently required for our battle against bacterial pathogens in the next
millennium.1. PAYNE, D. J., MARRIOTT, M. S. & AMYES S. G. B. (1991). Plasmid
mediated ceftazidime resistance identified in a strain of Serratia marcescens
isolated in Belgium. Journal of Antimicrobial Chemotherapy 27, 689 -693. •
2. PAYNE, D. J., MARRIOTT, M. S., CHRISTODOULOU, C. & AMYES S. G.
B. (1990). TEM -E4: A f 3- lactamase which confers transferable resistance to
ceftazidime. Journal of Pharmacy and Pharmacology 42, 61P. •
3. PAYNE, D. J., HOOD, J., MARRIOTT, M. S. & AMYES S. G. B. (1990).
Separation of plasmid mediated extended spectrum ß- lactamases by Fast
Protein Liquid Chromatography (FPLC system). FEMS Microbiology Letters
69, 195 -200. •
4. PAYNE, D. J., BLAKEMORE, P. H., DRABU, Y. & AMYES, S. G. B.
(1989). Comparison of the TEM -E3 and TEM -5 13- lactamases. Journal of
Antimicrobial Chemotherapy 24, 615 -617. •
5. PAYNE, D. J., MARRIOTT, M. S. & AMYES S. G. B. (1989). TEM -El: a
novel 13- lactamase conferring resistance to ceftazidime. FEMS Microbiology
Letters 59, 97 -100. •
6. PAYNE, D. J., MARRIOTT, M. S. & AMYES, S. G. B. (1989). Two novel
f3- lactamases which confer resistance to ceftazidime. Abst. 610/0S31. Fourth
European Congress of Clinical Microbiology, Nice, France. •
7. PAYNE, D. J., MARRIOTT, M. S. & AMYES, S. G. B. (1990). Comparison
of TEM -E3 and TEM -10 13- lactamases. Abst. A -70. 90th American Society for
Microbiology, Anaheim, California, USA. •
8. PAYNE, D. J., MARRIOTT, M. S. & AMYES, S. G. B. (1990).
Characterization of a unique ceftazidime hydrolyzing (3- lactamase, TEM -E2.
Journal of Medical Microbiology 32, 131 -134. •
9. PAYNE, D. J., MARRIOTT, M. S. & AMYES S. G. B. (1989). Mutants of the
TEM -1 13- lactamase conferring resistance to ceftazidime. Journal of
Antimicrobial Chemotherapy 24, 103 -110. •
10. PAYNE, D. J., MARRIOTT, M. S. & AMYES, S. G. B. (1989). Mutant
enzymes of the TEM -1 f3- lactamase conferring resistance to third generation
cephalosporins. Abst. PP2 /2. Western Pacific Congress on Infectious Diseases
and Chemotherapy, Kuala Lumpur, Malaysia. •
11. PAYNE, D. J., HOOD, J., PATON, R. & AMYES, S. G. B. (1990). Lack of
transferable third generation cephalosporin resistance in Scotland. Program and
Abst. 15. Western Pacific Congress on Infectious Diseases and Chemotherapy,
Pattaya, Thailand. •
12. WOODFORD, N., PAYNE, D. J., JOHNSON, A. P., WEINBREN, M. J.,
PERINPANAYAGAM, R. M., GEORGE, R. C., COOKSON, B. D. &
AMYES, S. G. B. (1991). Transferable cephalosporin resistance not inhibited
by clavulanic acid in Escherichia coli. Lancet 336, 8709, 253. •
13. PAYNE, D. J., WOODFORD, N. & AMYES S. G. B. (1992). Characterization
of the plasmid mediated 13- lactamase BIL -1. Journal of Antimicrobial
Chemotherapy 30, 119 -127. •
14. FOSBERRY, A. & PAYNE, D. J. (1992). BIL -l: an example of a plasmid
mediated Class C 13- lactamase. The Fifth 13- lactamase Workshop, Holy Island. •
15. FOSBERRY, A., PAYNE, D. J., LAWLOR, E. & HODGSON, J. (1994).
Cloning and sequence analysis of blaBIL -1: a plasmid mediated Class C
f3- lactamase gene in Escherichia coli BS. Antimicrobial Agents and
Chemotherapy 38, 1182 -1185. •
16. PAYNE, D. J. & KNOWLES, D. (1993). Plasmid mediated Class I
[3- lactamases. Abst. 482. European Congress of Clinical Microbiology, Seville,
Spain. •
17. AMYES, S. G. B., TAIT, S., THOMSON, C. J., PAYNE, D. J.,
NANDIVADA, L. S., JESUDASON, M. V., MUKUNDAN, U. D. & YOUNG
H -K. (1992). Incidence of antibacterial drug resistance in aerobic faecal flora in
South India. Journal of Antimicrobial Chemotherapy 29, 415 -427. •
18. TAIT, S., NANDIVADA, L. S., PAYNE, D. J., THOMSON, C. J. & AMYES,
S. G. B. (1990). Resistance to antibacterial drugs in commensal bacterial flora
in South India. Journal of Pharmacy and Pharmacology 42, 64P. •
19. AMYES, S. G. B., TAIT, S., THOMSON, C. J., PAYNE, D. J.,
MUKUNDAN, U. & JESUDASON, M.V. (1992). Reservoirs of antibiotic
resistance genes. Conference on Hospital Acquired Infections, Christian
Medical College Hospital, Vellore, Tamil Nadu, India. •
20. AMYES, S. G. B., NANDIVADA, L. S., PAYNE, D. J., TAIT, S.,
THOMSON, C. J., & JESUDASON, M. V. (1990). Incidence of antibacterial
drug resistance in commensal bacteria in South India. British Society for
Antimicrobial Chemotherapy, Brighton. •
21. PAYNE, D. J. & AMYES S. G. B. (1991). Comparison of the oral
cephalosporin cefdinir (CI -983, FK -482), with related beta -lactams on clinical
strains isolated in Scotland. In Recent Advances in Chemotherapy, Section I (
Eds: Adam, D., Lode, H. & Rubinstein, E.) p46 -47. Futuramed Publishers,
Munich, Germany. •
22. PAYNE, D. J. & AMYES S. G. B (1992). The sensitivity of clinical bacteria
isolated in Scotland to the oral cephalosporin, cefdinir. Drugs Under
Experimental and Clinical Research XVIII (6), 225 -231. •
23. PAYNE, D. J. & AMYES S. G. B. (1993). Stability of cefdinir to extended -
spectrum plasmid mediated 13- lactamases. Journal of Medical Microbiology 38,
114 -117. •
24. PAYNE, D. J. & AMYES S. G. B. (1991). Beta -lactamase stability of the oral
cephalosporin cefdinir (CI -983, FK -482) compared with related antibiotics. In
Recent Advances in Chemotherapy, Section I ( Eds: Adam, D., Lode, H. &
Rubinstein, E.) p66 -67. Futuramed Publishers, Munich, Germany. •
25. PAYNE, D. J., COLEMAN, K. & CRAMP, R. (1991). The automated in -vitro
assessment of f3- lactamase inhibitors. Journal of Antimicrobial Chemotherapy
28, 775 -776. •
26. PAYNE, D. J. & PRADHANANGA, S. L. (1996). A microtitre -based assay for
the determination of IDSO's of 13- lactamase inhibitors employing reporter
substrates detected at UV or visible wavelengths. Biotechnology International,
309- 312. Eds F. Fox, T. H. Connor, Universal Medical Press Inc. •
27. PAYNE, D. J. & PRADHANANGA, S. L., (1996). A microtitre -based assay
for the determination of IDSO's of (3- lactamase inhibitors employing reporter
substrates detected at UV or visible wavelengths. Application Note 1 -3,
Molecular Devices. •
28. CRAMP, R., PAYNE, D. J. & COLEMAN, K. (1993). Overcoming enzymatic
resistance to 13- lactams: rapid screening of 13- lactamase inhibitors. Abst. P17/7.
Seventh International Congress on Rapid Methods and Automation in
Microbiology and Immunology. •
29. PAYNE, D. J., CRAMP, R., WINSTANLEY, D. & KNOWLES, D. J. (1994).
Comparative activities of clavulanic acid, sulbactam, and tazobactam against
clinically important 13- lactamases. Antimicrobial Agents and Chemotherapy 38,
767 -772. •
30. PAYNE, D. J. & CRAMP, R. (1992). Determination of ID50 values for 35
plasmid mediated 13- lactamases. Abst. 10B. 7. International Congress on the
Management of Infection, Amsterdam. •
31. FARMER, T. H., DEGNAN, B. A. & PAYNE, D. J. (1999). Penetration of
(3- lactamase inhibitors into the periplasm of Gram negative bacteria. FEMS
Microbiology Letters 176, 11 -15. •
32. FARMER, T. H., PAGE, J., PAYNE, D. J. & KNOWLES, D. (1994). Kinetic
and physical studies of the 13- lactamase inhibition by a novel penem BRL
42715. Biochemical Journal 303, 825 -830. •
33. BATESON, J. H., GASSON, B. C., KHUSHI, T., NEALE, J. E., PAYNE, D.
J., TOLSON, D. A. & WALKER, G. (1994). The synthesis and serine
3- lactamase inhibitory activity of some phosphonamidates of dipeptides.
Biorganic & Medicinal Chemistry Letters 4, 1667 -1672. •
34. PAYNE, D. J., BATESON, J. H., TOLSON, D., GASSON, B., KHUSHI, T. &
READING, C. (1995). Inhibition of P99 by phosphonamidate analogues:
elucidation of the mechanism by ESMS. 6th (3- Lactamase Workshop, Holy
Island, 9 -13th April). •
35. PAYNE, D. J., BATESON, J. H., TOLSON, D., GASSON, B., KHUSHI, T.,
LEDENT, P. & FRERE, J. M. (1996). Phosphonamidate analogues of
dipeptides with carboxypeptidase A and (3- lactamase inhibitory activity:
Elucidation of the mechanism of (3- lactamase inhibition by ESMS.
Biochemical Journal 314, 457- 461. •
36. PAYNE, D. J., SKETT, P., APLIN, R. T., ROBINSON, C. & KNOWLES, D.
(1994). 3- lactamase ragged ends detected by electrospray mass spectrometry
correlates poorly with multiple banding on isoelectric focusing. Journal of
Biological Mass Spectrometry 23, 159 -164. •
37. PAYNE, D. J. & AMYES, S. G. B. (1994). The effects of 13- lactams on the
isoelectric focussing of 13- lactamases. Journal of Applied Bacteriology 76, 500-
505. •
38. DU, W., ORLEK, B., FAN, F., & PAYNE, D. J (1999). Inhibition of serine
beta -lactamases by lipopeptides. Abst. 191. 217th American Chemical Society
National Meeting, Anaheim, California, USA. •
39. PAYNE, D. J. (1993). Metallo- (3- lactamases- a new therapeutic challenge.
Journal of Medical Microbiology 39, 93 -99. •
40. PAYNE, D. J., CRAMP, R., BATESON, J. H., NEALE, J. & KNOWLES, D.
(1994). Rapid identification of serine and metallo -ß- lactamases Antimicrobial
Agents and Chemotherapy 38, 991 -996. •
41. PAYNE, D. J., CRAMP, R., BATESON, J. H., CLARKE, G. & KNOWLES,
D. (1993). Detection of metallo- and serine (3- lactamases from X.maltophilia.
Abst. 1522. Interscience Conference on Antimicrobial Agents and
Chemotherapy, New Orleans, Louisiana. •
42. PAYNE, D. J., ROWLING, P., KHUSHI, K., READING, C. & DODD, I.
(1994). Biochemical characterization of X.maltophilia metallo -13- lactamases
types 1 to 6 Abst. C60. Interscience Conference on Antimicrobial Agents and
Chemotherapy, Orlando, Florida, USA. •
43. PRADHANANGA, S. L., ROWLING, P. J. E., SIMPSON, I. N. & PAYNE, D.
J. (1996). Sensitivity of L -2 type 13- lactamases from Stenotrophomonas
maltophilia to serine active site (3- lactamase inhibitors. Journal of
Antimicrobial Chemotherapy 37, 394 -396. •
44. STUNT, R. A., THOMSON, C. J., PAYNE, D. J. & AMYES, S. G. B. (1998).
A study of the mechanisms involved in imipenem resistance in Pseudomonas
aeruginosa isolates from Japan. Journal Antimicrobial Chemotherapy 42, 272-
273. •
45. STUNT, R. A., THOMSON, C. J., PAYNE, D. J. & AMYES, S. G. B. (1998).
The production of a novel carbapenem -hydrolyzing (3- lactamase in Aeromonas
veronii biovar sobria and its association with imipenem resistance. Journal of
Antimicrobial Chemotherapy 42, 835 -836. •
46. STUNT, R. A., AMYES, A. K. B., THOMSON, C. J., PAYNE, D. J. &
AMYES, S. G. B. (1997). Isolation of imipenem resistant Aeromonas veronii
by sobria, that possess a novel carbapenemase, from a water source in India.
Abst. C -96. Interscience Conference on Antimicrobial Agents and
Chemotherapy, Toronto, Canada. •
47. STUNT, R. A., THOMSON, C. J., PAYNE, D. J. & AMYES, S. G. B. (1996).
A rapid substrate based technique for the detection and characterization of
carbapenemases in clinical isolates after IEF. Abst. C35. Interscience
Conference on Antimicrobial Agents and Chemotherapy, New Orleans, USA. •
48. MUNN, J. G. R., THOMSON, C. J., PAYNE, D. J. & AMYES, S. G. B.
(1995). Prevalence of metallo -13- lactamases in clinical isolates of
Flavobacterium. Panceltic Microbiology Society, Dublin, Ireland. •
49. MUNN, J. G. R., PAYNE, D. J., ROWLING, P. J. E., THOMSON, C. J &
AMYES, S. G. B. (1995). Isolation and characterization of two f3- lactamases
from a clinical isolate of Flavobacterium spiritivorum. 7th European Congress
of Clinical Microbiology and Infectious Diseases, Vienna. •
50. MUNN, J. G. R., THOMSON, C. J., PAYNE, D. J. & AMYES, S. G. B.
(1994). Characterization of imipenem hydrolysing metallo -13- lactamases from
2 Bacteroides fragilis clinical isolates. Abst. A61. 94th General Meeting of the
American Society of Microbiology, Las Vegas, Nevada, USA. •
51. WALSH, T. R., PAYNE, D.J., McGOWAN, P. & BENNETT, P.M. (1995). A
clinical isolate of A.sobria, strain 163a, possesses three chromosomally
mediated inducible ß- lactamases, a cephalosporinase, a penicillinase and a
metallo- 13- lactamase. Journal of Antimicrobial Chemotherapy 35, 271 -279. •
52. WALSH, T. R., NEVILLE, W. A., HARAN, M. H., TOLSON, D., PAYNE, D.
J. , BATESON, J. H., MACGOWAN, A. P. & BENNETT, P. M. (1998).
Nucleotide and amino acid sequences of the metallo -13- lactamase ImiS from
Aeromonas veronii by. sobria. Antimicrobial Agents Chemotherapy 42, 436-
439. •
53. KHUSHI, T., PAYNE, D.J., FOSBERRY, A. & READING, C. (1996).
Production of metal dependent 13- lactamases by clinical strains of B.fragilis
isolated before 1987. Journal of Antimicrobial Chemotherapy 37, 345 -350. •
54. PAYNE, D. J., BETRIU, C., KHUSHI, T., HOYLE, C., READING, C. &
KNOWLES, D. (1995). Imipenem hydrolyzing (3- lactamases from 6 strains of
B.fragilis. Abst. A75. 95th General Meeting of the American Society of
Microbiology, Washington, D. C, USA. •
55. GILPIN, M., FULSTON, M., PAYNE, D. J., CRAMP, R. & HOOD, I. (1995).
Isolation and structure determination of two novel phenazines from a
Streptomycete with inhibitory activity against metalloenzymes including
metallo-(3-lactamase. Journal of Antibiotics 48, 1081 -1085. •
56. PAYNE, D. J., BATESON, J. H., PROCTOR, D., KHUSHI, T., FARMER, T.
H., TOLSON, A. D., BELL, D., SKETT, P. W., MARSHALL A. C., REID, R.,
GHOSEZ, L. Y., COMBRET, Y. & MARCHAND-BRYNAERT, J. (1996).
Inhibition of metallo-13- lactamases by a series of mercaptoacetic acid
thiolester derivatives. Antimicrobial Agents and Chemotherapy 41, 135 -140. •
57. PAYNE, D. J., BATESON, J. H., GASSON, B. C., KHUSHI, T., PROCTOR,
D., PEARSON, S. & REID, R. (1997). Inhibition of metallo- 13- lactamases by a
series of thiol ester derivatives of mercaptophenylacetic acid. FEMS
Microbiology Letters 157, 171 -175. •
58. PAYNE, D. J., BATESON, J. H., CHEEVER, C., FARMER, T., GILPIN, M.,
NICONOVICH, N., PEARSON, S., RITTENHOUSE, S. & WITTY, D.
(1999). Potent, broad -spectrum, mercaptocarboxylate inhibitors of metallo-(3-
lactamases (MBLs). Abst. A10. 99th American Society of Microbiology
General Meeting, Chicago, IL, USA. •
59. GILPIN, M., BEST, D., WITTY, D., BATESON, J.H., PEARSON, S,
CHEEVER, C., NICONOVICH, N., RITTENHOUSE, S. & PAYNE, D. J.
(2000). SAR and selectivity analysis of a series of thiazolidine and proline
mercaptocarboxylate MBL inhibitors. Abst. 1225. Interscience Conference on
Antimicrobial Agents and Chemotherapy, Toronto, Canada 2000. •
60. BATESON, J. H., WITTY, D. R., GASSON, B. C., BEST, D. J. & PAYNE, D.
J.(1997). Beta -thiopropionyl- aminoacid derivatives and their use as
beta -lactamase inhibitors. WO09730027A1. •
61. GILPIN, M. L., PAYNE, D. J. & BATESON, J. H. (1997). Pyrrolidine and
thiazole derivatives with antibacterial and metallo- beta -lactamase inhibitory
properties. WO09710225. •
62. FABIANE, S.M., SOHI, M., WAN, T., PAYNE, D. J., BATESON, J. H. &
SUTTON, B. J. (1996). Crystal structure of a metallo f3- lactamase II from
B.cereus at 2.5 A. Abst. PSO4.02.22. International Congresss of
Crystallography XVII, Seatle, Washington. •
63. FABIANE, S. M., SOHI, M. K., WAN, T., PAYNE, D. J., BATESON, J. H.,
MITCHELL, T. & SUTTON, B. J. (1998). The crystal structure of the zinc -
dependent metallo -(3- lactamase II from Bacillus cereus at 1.9Á resolution.
Biochemistry 37, 12404 -12411. •
64. CONCHA, N. O., JANSON C. A., GASSON, B. C., ROWLING, P.,
PEARSON, S., CHEEVER, C. A., CLARKE B. P., LEWIS, C., PAYNE, D.
J., BATESON, J. H. & ABDEL- MEGUID, S. S (2000). The crystal structure of
the IMP -1 metallo (3- lactamase from Pseudomonas aeruginosa and its complex
with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad -
spectrum inhibitor. Biochemistry 39, 4288 -4298. •
65. DU, W., BATESON, J. H., GILPIN, M. WITTY, D. & PAYNE, D. J. (1999).
Unusual inhibition of serine beta -lactamases by mercaptocarboxylate inhibitors
of metallo- beta -lactamase. Abst. A -4. 99th. American Society of Microbiology
General Meeting, Chicago, Il, USA. •
66. PAYNE, D. J. & AMYES S. G. B. (1991). Transferable resistance to extended
spectrum 13- lactams: a major threat or a minor inconvenience. Journal of
Antimicrobial Chemotherapy 27, 255 -261. (LEADING ARTICLE) •
67. PAYNE, D. J. (1996) Laboratory detection and investigation of zinc
13- lactamases. Invited speaker, European Congress of Chemotherapy, Glasgow
UK. Abstr. C17. •
68. PAYNE, D. J. (1992). 13- lactamase mediated resistance in nosocomial
infections. Conference on Hospital Acquired Infections, Christian Medical
College Hospital, Vellore, Tamil Nadu, India. •
69. AMYES, S. G. B., PAYNE, D. J. & DU BOIS, S. K. (1992). Plasmid mediated
3- lactamases responsible for penicillin and cephalosporin hydrolysis. Journal
of Medical Microbiology 36, 6 -9. •
70. COLEMAN, K., PAYNE, D. J., SIMPSON, I. N. & THORBURN, C. (1993).
Highlights of the 6th European Congress of Clinical Microbiology and
Infectious Diseases. Current Opinions on Investigational Drugs 2, (7) 851 -852. •
71. PEARSON, S., LONSDALE, J. T. & PAYNE, D. J. (1996). Review of the
Infectious diseases manual. Journal Antimicrobial Chemotherapy 39, 113 -114. •
72. PAYNE, D. J. & FARMER, T. (1998) Biochemical and enzyme kinetic
applications for the characterization of (3- lactamases. From: Methods in
Molecular Medicine, Vol 15: Molecular Bacteriology: Protocols and Clinical
Applications Edited by Woodford, N and Johnson, A. Humana Press Inc. •
73. PAYNE, D. J. & THOMSON, C. J. (1998) Molecular approaches for the
detection and identification of (3- lactamases. From: Methods in Molecular
Medicine, Vol 15: Molecular Bacteriology: Protocols and Clinical Applications
Edited by Woodford, N and Johnson, A. Humana Press Inc. •
74. COLEMAN, K., ATHALYE, M., CLANCEY, A., DAVISON, M., PAYNE, D.
J., PERRY, C. & CHOPRA, I. (1994). Bacterial resistance mechanisms as
therapeutic targets. Journal of Antimicrobial Chemotherapy, 33, 1091 -1116. •
75. PAYNE, D. J., DU, W. & BATESON, J.H. (2000). 13- lactamase epidemiology
and the utility of established and novel ß- lactamase inhibitors. Expert Opinions
Invest. Drugs, 9(2), 247 -261. •
76. PAYNE, D. J. (1999). Metallo -(3- lactamase inhibitors: disarming an undesired
factory. Conference on Controlling the Proliferation of the Microbial Cell
Factory. European Commission Sectoral Meeting. Verona, Italy. •
77. PAYNE, D. J. (1999) Broad spectrum inhibitors of metallo -(3- lactamases. 3rd
International Antibacterial Drug Discovery and Development Summit.
Princeton. NJ. USA. •
78. PAYNE, D. J. (1999) Discovery of novel inhibitors of metallo -13- lactamases.
40th Annual Buffalo Medicinal Chemistry Symposium. Buffalo, NY, USA. •
79. UTRUP, L. J., Rl TTERNHOUSE, S. F., PAYNE, D. J., PERRY, C. R. &
POUPARD, J. A. (1993). Providencia producing discrepant results with
ampicillin and Augmentin have 13- lactamases with high isoelectric points. Abst.
A88. 93rd American Society of Microbiology, Atlanta, Georgia, USA. •
80. PAYNE, D. J. (1997) The search for new antibacterial agents - new
approaches. Invited speaker, Royal College of Physicians of Edinburgh,
Symposium on Infectious Diseases and Travel Medicine, Edinburgh, UK. •
81. PAYNE, D. J. (2000). Bacterial fatty acid biosynthesis: A genomics drivern
target. 4th International Antibacterial Drug Discovery and Development
Summit, Princeton, NJ, USA. •
82. DEBOUCK, C., GENTRY, D. R., LONSDALE, J. T., MOONEY, J. L.,
PAYNE, D. J., PEARSON, S. C., SHILLING, L. K., VAN ALLER, G.,
WANG, M. & ZHONG, Y. Y. (1999). Staphylococcus aureus FabH. Patent
Number: EP- 916730 -A2. •
83. GENTRY, D. R., LONSDALE, J. T., PAYNE, D. J., PEARSON, S. C. &
VAN ALLER, G. (1998). Streptococcus pneumoniae FabD. WO9822133 -A1. •
84. GENTRY, D. R., LONSDALE, J. T., PAYNE, D. J. & PEARSON, S. C.
(1998). Staphylococcus aureus Fab D polynucleotides. US5,827,689. •
85. GENTRY, D. R., LONSDALE, J. T., PAYNE, D. J. & PEARSON, S. C.
(1998) Streptococcus pneumoniae FabH -
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
Author-wise bibliometric analysis based on entropy.
No full textAuthor-wise bibliometric analysis based on entropy.</p
- …
